(Press-News.org) Since the first immunotherapy drug to boost the body’s immune response against advanced lung cancer was introduced in the United States in 2015, survival rates of patients with the disease have improved significantly. That’s the conclusion of a recent real-world study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
For the research, a team led by Dipesh Uprety, MD, FACP, of the Barbara Ann Karmanos Cancer Institute and the Wayne State University School of Medicine, analyzed data from the National Cancer Institute Surveillance, Epidemiology, and End Results database, which compiles cancer-related data covering approximately 48% of the US population. The investigators’ analysis focused on non–small cell lung cancer (NSCLC), which accounts for up to 90% of all cases of lung cancer and is the leading cause of cancer-related death among both men and women in the United States.
In a comparison of 100,995 patients with metastatic NSCLC treated in 2015–2020 (after immunotherapy was deemed the standard of care) and 90,807 patients with metastatic NSCLC in the pre-immunotherapy era of 2010–2014, patients in the immunotherapy era were less likely to die from any cause. The overall survival rates at one, three, and five years were 40.1% versus 33.5%, 17.8% versus 11.7%, and 10.7% versus 6.8%. The median overall survival was eight months in patients in the immunotherapy era and seven months in those in the pre-immunotherapy era.
Similarly, patients treated after immunotherapy was available were less likely to die specifically from cancer than those treated before immunotherapy. The one-, three-, and five-year cancer-specific survival rates were 44.0% versus 36.8%, 21.7% versus 14.4%, and 14.3% versus 9.0%, with a median survival of 10 months versus eight months.
Survival rates remained significantly better in the immunotherapy era even after accounting for factors including age, sex, race, income, and geographical area.
“By utilizing a large national database, our study provided real-world evidence of the positive impact of immunotherapy in patients with lung cancer,” said Dr. Uprety. The investigators stressed that additional studies are needed, however. “Immunotherapy provides long-term benefits. Since the durable benefits of immunotherapy are limited to a small subset of patients, future research should aim to optimize immunotherapy with new agents that can benefit a broader population,” said lead author Yating Wang, MD, of Ascension Providence Hospital.
Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the CANCER Newsroom upon online publication. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com
Full Citation:
“Survival Trends Among Patients with Metastatic Non–Small Cell Lung Cancer (NSCLC) Before and After the Approval of Immunotherapy in the United States: A Surveillance, Epidemiology, and End Results (SEER) Database-Based Study.” Yating Wang, Kyle Kondrat, Janak Adhikari, Quynh Nguyen, Qian Yu, and Dipesh Uprety. CANCER; Published Online: July 10, 2024 (DOI: 10.1002/cncr.35476)
URL: http://doi.wiley.com/10.1002/cncr.35476
Author Contact:
Jasmine Brown, Manager of Marketing and Communications at the Barbara Ann Karmanos Cancer Institute, brownja@karmanos.org or 248-226-2154
Julie O’Connor, Director of Research Communications at Wayne State University, julie.oconnor@wayne.edu or 313-577-8845
About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online. Follow CANCER on X @JournalCancer and Instagram @ACSJournalCancer, and stay up to date with the American Cancer Society Journals on LinkedIn.
About Wiley
Wiley is a knowledge company and a global leader in research, publishing, and knowledge solutions. Dedicated to the creation and application of knowledge, Wiley serves the world’s researchers, learners, innovators, and leaders, helping them achieve their goals and solve the world's most important challenges. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.
END
Deaths from advanced lung cancer have dropped significantly since immunotherapy became standard-of-care
The largest population-based study to date supports the survival benefits of immunotherapy for people with metastatic non–small cell lung cancer
2024-08-05
ELSE PRESS RELEASES FROM THIS DATE:
Air quality regimes around the world are playing catch up as science evolves and policy ambitions are too blunt, researchers say
2024-08-05
The failure to co-ordinate legal, policy and scientific thinking risks “a squandering of opportunity” to improve air quality, concludes new environmental law research, co-led by a UCL academic.
In their Science paper, ‘Harnessing science, policy and law to deliver clean air’, Professors Eloise Scotford (UCL Faculty of Laws), Alastair Lewis (University of York) and Delphine Misonne (UCLouvain Saint-Louis, Brussels) review recent research and highlight significant risks to achieving clean air globally.
Despite significant achievements in air quality law and policy in some parts of the world ...
Engineers develop general, high-speed technology to model, understand catalytic reactions
2024-08-05
AMES, Iowa – Researchers have been studying the industrial production of ammonia for a century. But they’ve struggled to find ways to improve the low-yield, low-efficiency process.
Atmospheric nitrogen, with the aid of an iron catalyst, reacts with hydrogen to produce ammonia. That reaction produces lots of ammonia – worldwide production is 160 million tons every year. Most is used in agriculture, especially as nitrogen fertilizer. It’s also used in many industries, including refrigeration ...
New $1.9 million PSU grant aims to improve outcomes for students with disabilities
2024-08-05
Improving outcomes for students with disabilities as they transition from high school to postsecondary education and employment starts with effective training and development opportunities for the secondary educators who support them.
Portland State University (PSU) has received a $1.9 million grant to redesign, implement and test a professional development model that aims to provide essential training for secondary educators. The grant, awarded by the U.S. Department of Education’s prestigious Institute of Education Sciences, will fund a four-year project titled "Transition Coalition Self-Study Plus (TCSS+): A ...
In law enforcement, a link between head injuries and depression, PTSD
2024-08-05
COLUMBUS, Ohio – A new study is the first to shed light on the high prevalence of head injuries, and related mental health symptoms, in a previously overlooked population when it comes to concussion surveillance: law enforcement officers.
The survey of Ohio law enforcement officers found that 74% reported a lifetime history of one or more head injuries, and 30% had a head injury that happened on the job. Many more of these injuries went unreported than were treated by a health care professional. And further analysis showed post-traumatic stress disorder and depressive symptoms were higher in those who had experienced one or more head injuries.
“This ...
Successful pregnancies after allogeneic hematopoietic cell transplantation – results of a national study
2024-08-05
A new national multicenter study offers hope for women who have undergone allogeneic hematopoietic cell transplantation (alloHCT). The results of the study, recently published in the renowned journal Blood, show that successful pregnancies are possible under certain conditions, especially in younger women, patients with non-malignant diseases, and those who received no or only low doses of total body irradiation (TBI).
For many benign hematologic disorders, allogeneic hematopoietic cell transplantation (alloHCT) is the only ...
Sanders-Brown Center on Aging launches innovative Brain Health Activities program
2024-08-05
LEXINGTON, Ky. (Aug. 2, 2024) – The University of Kentucky’s Sanders-Brown Center on Aging has introduced a groundbreaking initiative, Brain Health Activities, aimed at supporting individuals with dementia and their caregivers. The program was developed with extensive collaboration across the UK campus, offering a variety of resources designed to enhance brain health and quality of life for those affected by dementia and their caregivers.
The idea for ...
Nature's design marvel: How shark skin's denticles adapt to wide speed
2024-08-05
New findings on how sharks achieve drag reduction could inspire the design of riblets for more efficient aircraft and boats. In their investigation of great white shark denticles, researchers from Tokyo Tech found that ridge height and spacing play crucial roles in drag reduction at different swimming speeds. Higher middle ridges aid sharks in efficient cruising at slower speeds, while the lower side ridges become more critical for drag reduction during high-speed hunting bursts. The analysis also suggests that the speeds of an extinct giant ...
Ultrafine particles linked to over 1,000 deaths per year in Canada’s two largest cities
2024-08-05
A first-of-its kind study conducted in Canada’s two largest cities by McGill-led researchers has linked about 1,100 premature deaths per year to an unregulated air pollutant.
Ultrafine particles (UFPs) primarily come from vehicle emissions and industrial activities. Canada’s federal and provincial governments have not set concentration limits for UFPs, as they have for larger fine particles known as PM2.5.
“Ultrafine particles are incredibly small, allowing them to penetrate deep into the lungs and enter the bloodstream. Increasing evidence suggests these pollutants may contribute to heart and lung diseases, as well as certain forms of cancer,” ...
Physicists develop new method to combine conventional internet with the quantum internet
2024-08-05
Four researchers from the Institute of Photonics at Leibniz University Hannover have developed a new transmitter-receiver concept for transmitting entangled photons over an optical fiber. This breakthrough could enable the next generation of telecommunications technology, the quantum Internet, to be routed via optical fibers. The quantum Internet promises eavesdropping-proof encryption methods that even future quantum computers cannot decrypt, ensuring the security of critical infrastructure.
"To make the quantum Internet a reality, we need to transmit entangled photons via fiber optic networks,” says Prof. Dr. Michael Kues, Head of the Institute ...
Don't drink raw milk. But what about raw milk cheese? (video)
2024-08-05
WASHINGTON, Aug. 5, 2024 — A lot of people on the internet have been telling our host Alex to drink raw milk. This is a bad idea — a particularly bad one actually. So she wanted to make a video about why it’s such a bad idea to consume raw milk, then she realized she’s been eating raw milk without even knowing it via cheese. That’s when things got complicated.
Reactions is a video series produced by the American Chemical Society and PBS Digital Studios. Subscribe to Reactions and follow us on X, formerly Twitter @ACSReactions.
The American Chemical Society ...
LAST 30 PRESS RELEASES:
Opening borders for workers: Abe’s profound influence on Japan’s immigration regime
How skills from hospitality and tourism can propel careers beyond the industry
Research shows managers of firms handling recalls should review media scrutiny before deciding whether to lobby
New model system for the development of potential active substances used in condensate modifying drugs
How to reduce social media stress by leaning in instead of logging off
Pioneering research shows sea life will struggle to survive future global warming
In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery
Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023
Repurposing semaglutide and liraglutide for alcohol use disorder
IPK-led research team provides insights into the pangenome of barley
New route to fluorochemicals: fluorspar activated in water under mild conditions
Microbial load can influence disease associations
Three galactic “red monsters” in the early Universe
First ever study finds sexual and gender minority physicians and residents have higher levels of burnout, lower professional fulfillment
Astronomers discover mysterious ‘Red Monster’ galaxies in the early Universe
The secrets of fossil teeth revealed by the synchrotron: a long childhood is the prelude to the evolution of a large brain
Obesity-fighting drugs may reduce alcohol consumption in individuals with alcohol use disorder
Does AI improve doctors’ diagnoses? Study puts it to the test
Extreme weather accelerates nitrate pollution in groundwater
Burden of liver cancer attributable to hepatitis B and alcohol globally, in China, and for five sociodemographic index regions from 1990 to 2021
Lehigh partners with North Carolina A&T to enhance flood damage mapping with AI and advanced radar
2024 AAAS Kavli Science Journalism Award winners named
Collaborative of prominent academic institutions launches groundbreaking healthcare AI challenge
American Federation for Aging Research announces 2024 AFAR grants for junior faculty
Potential single-dose smallpox and mpox vaccine moves forward
Mass General Brigham Gene and Cell Therapy Institute names Spark Grant recipients
New discovery may lead to more effective treatment for cardiovascular disease
Developing advanced recycling technology to restore spent battery cathode materials
An advance toward inhalable mRNA medications, vaccines
A step toward safer X-rays with new detector technology
[Press-News.org] Deaths from advanced lung cancer have dropped significantly since immunotherapy became standard-of-careThe largest population-based study to date supports the survival benefits of immunotherapy for people with metastatic non–small cell lung cancer